SG10201806532RA - Proteins targeting orthologs - Google Patents

Proteins targeting orthologs

Info

Publication number
SG10201806532RA
SG10201806532RA SG10201806532RA SG10201806532RA SG10201806532RA SG 10201806532R A SG10201806532R A SG 10201806532RA SG 10201806532R A SG10201806532R A SG 10201806532RA SG 10201806532R A SG10201806532R A SG 10201806532RA SG 10201806532R A SG10201806532R A SG 10201806532RA
Authority
SG
Singapore
Prior art keywords
orthologs
proteins targeting
polypeptide
present
methods
Prior art date
Application number
SG10201806532RA
Inventor
Jay Short
Original Assignee
Bioatla Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioatla Llc filed Critical Bioatla Llc
Publication of SG10201806532RA publication Critical patent/SG10201806532RA/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes

Abstract

PROTEINSTARGETING ORTHOLOGS The present invention is relevant to polypeptides and novel methods of polypeptide evolution. The present invention further relates to methods of identifying a cross-species mutant polypeptide from, or based upon, a template polypeptide. (FIGURE ) 110
SG10201806532RA 2014-01-07 2015-01-07 Proteins targeting orthologs SG10201806532RA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201461924487P 2014-01-07 2014-01-07

Publications (1)

Publication Number Publication Date
SG10201806532RA true SG10201806532RA (en) 2018-09-27

Family

ID=53524311

Family Applications (1)

Application Number Title Priority Date Filing Date
SG10201806532RA SG10201806532RA (en) 2014-01-07 2015-01-07 Proteins targeting orthologs

Country Status (9)

Country Link
US (2) US11293929B2 (en)
EP (2) EP3447493B1 (en)
CN (2) CN105849564B (en)
AU (2) AU2015204840B2 (en)
CA (1) CA2935577C (en)
DK (2) DK3092491T3 (en)
ES (2) ES2709388T3 (en)
SG (1) SG10201806532RA (en)
WO (1) WO2015105888A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3966227A1 (en) 2019-05-07 2022-03-16 Voyager Therapeutics, Inc. Compositions and methods for the vectored augmentation of protein destruction, expression and/or regulation
US20220414855A1 (en) * 2021-06-25 2022-12-29 Fei Company Area selection in charged particle microscope imaging

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154598B (en) 1970-11-10 1977-09-15 Organon Nv PROCEDURE FOR DETERMINING AND DETERMINING LOW MOLECULAR COMPOUNDS AND PROTEINS THAT CAN SPECIFICALLY BIND THESE COMPOUNDS AND TEST PACKAGING.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4196265A (en) 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies
US4704362A (en) 1977-11-08 1987-11-03 Genentech, Inc. Recombinant cloning vehicle microbial polypeptide expression
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4361549A (en) 1979-04-26 1982-11-30 Ortho Pharmaceutical Corporation Complement-fixing monoclonal antibody to human T cells, and methods of preparing same
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4957858A (en) 1986-04-16 1990-09-18 The Salk Instute For Biological Studies Replicative RNA reporter systems
US4883750A (en) 1984-12-13 1989-11-28 Applied Biosystems, Inc. Detection of specific sequences in nucleic acids
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
AU622104B2 (en) 1987-03-11 1992-04-02 Sangtec Molecular Diagnostics Ab Method of assaying of nucleic acids, a reagent combination and kit therefore
AU622426B2 (en) 1987-12-11 1992-04-09 Abbott Laboratories Assay using template-dependent nucleic acid probe reorganization
AU624601B2 (en) 1988-01-21 1992-06-18 Genentech Inc. Amplification and detection of nucleic acid sequences
CA1340807C (en) 1988-02-24 1999-11-02 Lawrence T. Malek Nucleic acid amplification process
EP0365627B1 (en) 1988-03-24 1993-12-22 University Of Iowa Research Foundation Catalytic hybridization systems for the detection of nucleic acid sequences based on their activity as cofactors in catalytic reactions in which a complementary labeled nucleic acid probe is cleaved
WO1993012227A1 (en) 1991-12-17 1993-06-24 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
DE69333243T2 (en) 1992-11-24 2004-08-19 G.D. Searle & Co., Chicago MUTTED INTERLEUKIN-3 (IL-3) POLYPEPTIDES
US6562594B1 (en) 1999-09-29 2003-05-13 Diversa Corporation Saturation mutagenesis in directed evolution
US6171820B1 (en) 1995-12-07 2001-01-09 Diversa Corporation Saturation mutagenesis in directed evolution
US6764835B2 (en) 1995-12-07 2004-07-20 Diversa Corporation Saturation mutageneis in directed evolution
US5874304A (en) * 1996-01-18 1999-02-23 University Of Florida Research Foundation, Inc. Humanized green fluorescent protein genes and methods
US7033781B1 (en) 1999-09-29 2006-04-25 Diversa Corporation Whole cell engineering by mutagenizing a substantial portion of a starting genome, combining mutations, and optionally repeating
RU2363707C2 (en) 2001-02-19 2009-08-10 Мерк Патент Гмбх Artificial proteins with lowered adjuvanticity
US8843356B2 (en) * 2002-12-27 2014-09-23 Merck Sharp & Dohme Corp. Computer systems and methods for associating genes with traits using cross species data
KR20080073293A (en) 2005-10-14 2008-08-08 메디뮨 엘엘씨 Cell display of antibody libraries
LT2520590T (en) * 2007-04-03 2018-09-10 Amgen Research (Munich) Gmbh Cross-species-specific binding domain
MX2009010611A (en) * 2007-04-03 2010-03-26 Micromet Ag Cross-species-specific bispecific binders.
WO2009059235A2 (en) 2007-11-01 2009-05-07 Facet Biotech Corporation Immunoglobulin display vectors
EP2153844A1 (en) 2008-08-14 2010-02-17 HAUBECK, Hans-Dieter Human hyaluronidases for axonal regrowth
US9260522B2 (en) * 2008-10-01 2016-02-16 Amgen Research (Munich) Gmbh Bispecific single chain antibodies with specificity for high molecular weight target antigens
AU2009299794B2 (en) * 2008-10-01 2015-08-13 Amgen Research (Munich) Gmbh Cross-species-specific single domain bispecific single chain antibody
US8312249B1 (en) 2008-10-10 2012-11-13 Apple Inc. Dynamic trampoline and structured code generation in a signed code environment
ES2652340T3 (en) 2009-07-17 2018-02-01 Bioatla Llc Simultaneous and integrated selection and evolution of performance and expression of human proteins in production hosts
FR2957821B1 (en) 2010-03-24 2014-08-29 Inst Francais Du Petrole NEW AREA OF CATALYST REGENERATION DIVIDED IN SECTORS FOR REGENERATIVE CATALYTIC UNITS
CA2804746C (en) * 2010-07-16 2022-01-11 Jay M. Short Novel methods of protein evolution
WO2012092376A2 (en) 2010-12-31 2012-07-05 Short Jay M Comprehensive monoclonal antibody generation

Also Published As

Publication number Publication date
EP3092491A1 (en) 2016-11-16
EP3092491A4 (en) 2017-03-29
AU2020202783B2 (en) 2022-08-25
AU2015204840B2 (en) 2020-01-30
CN105849564A (en) 2016-08-10
CA2935577A1 (en) 2015-07-16
EP3447493A1 (en) 2019-02-27
AU2015204840A1 (en) 2016-05-19
WO2015105888A1 (en) 2015-07-16
US20180259536A1 (en) 2018-09-13
EP3447493B1 (en) 2020-05-13
US11293929B2 (en) 2022-04-05
US20220341941A1 (en) 2022-10-27
CN105849564B (en) 2021-06-25
CA2935577C (en) 2023-04-04
ES2709388T3 (en) 2019-04-16
EP3092491B1 (en) 2018-10-31
CN113504375A (en) 2021-10-15
AU2020202783A1 (en) 2020-05-14
CN113504375B (en) 2024-01-09
DK3447493T3 (en) 2020-08-17
ES2819865T3 (en) 2021-04-19
DK3092491T3 (en) 2019-02-11

Similar Documents

Publication Publication Date Title
AU2019284081A1 (en) Food compositions comprising recombinant milk proteins and methods of producing the same
ZA201705114B (en) Cysteine protease
ZA201705113B (en) Cysteine protease
PH12017500861A1 (en) Anti-interleukin-33 antibodies and uses thereof
EP3708660A3 (en) Polypeptides
MY198059A (en) Anti-ox40 antibodies and their uses
MX2016016301A (en) Seed train processes and uses thereof.
MX2017006127A (en) Methods and compositions for egg white protein production.
MX2017016169A (en) Anti-her2 antibodies and methods of use.
PH12017502207A1 (en) Tau-binding antibodies
TR201909037T4 (en) The new protein deamidase.
MX2020004419A (en) Modified meningococcal fhbp polypeptides.
MX2017000776A (en) Modified meningococcal fhbp polypeptides.
MX2020010951A (en) Anti-hla-g antibodies and use thereof.
SG10201902596TA (en) Novel methods of protein evolution
MX2016000095A (en) Neurodegenerative disorders.
AU2015348922A8 (en) Codon optimized polynucleotide for high level expression of CRM197
EA201892624A1 (en) PLANTS GIVING SEEDLESS FRUITS
PH12016501689B1 (en) Tatk-cdkl5 fusion proteins, compositions, formulations, and use thereof
MX2017008908A (en) Process for the hydrolysis of keratin employing proteases.
PH12020550871A1 (en) Process for the preparation of opicapone and intermediates thereof
PH12016501629A1 (en) Uti fusion proteins
MX2017008286A (en) Novel methods for displaying cyclic peptides on bacteriophage particles.
PH12016501326A1 (en) (s)-3'-methyl-abscisic acid and esters thereof
SG10201806532RA (en) Proteins targeting orthologs